产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | A20 (小鼠B细胞淋巴瘤) (STR鉴定正确) |
| 别称 | A-20 |
| 种属 | 小鼠 |
| 生长特性 | 悬浮，聚团生长 |
| 细胞形态 | 圆形至多形细胞悬浮生长，单个或部分小集合，少数细胞轻微贴壁 |
| 冻存条件 | 冻存液：55% 基础培养基+40% FBS+5% DMSO 温度：液氮 |
| 培养方案A（默认） |
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 2×10^5-1×10^6cells/mL |
| 推荐换液频率 | 2-3次/周 |
| 背景描述 | A20 is a BALB/c B cell lymphoma line derived from a spontaneous reticulum cell neoplasm found in an old BALB/cAnN mouse. This cell line can be used in immunology research. |
| 组织来源 | B淋巴细胞；淋巴瘤 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 肉瘤细胞 |
| 生物安全等级 | BSL-1 |
| 倍增时间 | ~32 hours |
| 抗原表达情况 | I-A+ Ref |
| 基因表达情况 | immunoglobulin (surface, sIg+) I-A+ |
| 应用领域 | 3D cell culture Immunology |
| 保藏机构 | ATCC; TIB-208 BCRC; 60556 |
STR鉴定
-
STR位点信息
18-3 16,18 6-7 11,12 5-5 14,15 X-1 25 1-2 17,18 7-1 25.2 8-1 12,13 1-1 15,16 19-2 14 15-3 22.3 12-1 16 6-4 18 4-2 21.3 3-2 13,14 2-1 15 13-1 16.2,17.2
11-2 17 17-2 16,17 -
STR鉴定图
-
参考文献
-
Overcoming the On-Target Toxicity in Antibody-Mediated Therapies via an Indirect Active Targeting Strategy (2023-01-22)
作者：Zhongjie Tang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Xiaoyou Wang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Mei Tang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Jin Wu:1.Department of Breast and Thyroid Surgery, Southwest Hospital, Chongqing, 400038, P. R. China. ; Jiexuan Zhang:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Xinlong Liu:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Feiyan Gao:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, P. R. China. ; Yu Fu:1.Medical Research Institute, College of Pharmaceutical Sciences, Southwest U
期刊：Overcoming the On-Target Toxicity in Antibody-Mediated Therapies via an Indirect Active Targeting Strategy
影响因子 ：15.1
引用产品： 4T1 细胞 , MCF7 [MCF-7] 细胞 , A549 [A-549] 细胞 , A20 细胞 , RM-1 细胞 , NCI-N87 [N87] 细胞 , TE-1 细胞 , P388D1 细胞 , HPAC 细胞
-
BLK positively regulates TLR/IL-1R signaling by catalyzing TOLLIP phosphorylation (2023-12-11)
作者：Wei-Wei Li:1.State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China. ; 2.Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences , Wuhan, China. ; 3.Gansu Province Research Center for Basic Disciplines of Pathogen Biology , Lanzhou, China. ; Xu-Xu Fan:1.State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China. ; 2.Gansu Province Research Center for Basic Disciplines of Pathogen Biology , Lanzhou, China. ; Zhi-Sheng Xu:1.Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences , Wuhan, China. ; Zi-Xiang Zhu:
期刊：BLK positively regulates TLR/IL-1R signaling by catalyzing TOLLIP phosphorylation
影响因子 ：7.8
引用产品： U-87 MG 细胞 , Jurkat, Clone E6-1 细胞 , Raji 细胞 , A20 细胞
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
